BEIJING, June 16 (Reuters) – Novo Nordisk plans to seek Chinese regulatory approval for its Wegovy weight-loss pill "very soon," its CEO said on Tuesday, as it moves to catch up with rival Eli Lilly
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Colombia's Rodriguez retires from international football
VIDEO SHOWS: ARCHIVE PHOTOS & FOOTAGE OF JAMES RODRIGUEZ DURING HIS INTERNATIONAL CAREER WITH COLOMBIA…
Browns place RB Dylan Sampson (knee) on injured reserve
Cleveland Browns placed Dylan Sampson on injured reserve on Tuesday with a knee injury and…
Prosecutors rule out death penalty for son of slain filmmaker Rob Reiner
By Steve Gorman and Lisa Richwine LOS ANGELES, Sept 15 (Reuters) - Prosecutors said on…
